Catalent, Inc. Announces Second Quarter Fiscal Year 2019 Earnings Conference Webcast
January 14 2019 - 4:15PM
Business Wire
Catalent, Inc. (NYSE: CTLT) (“Catalent”), the leading global
provider of advanced delivery technologies and development
solutions for drugs, biologics, and consumer health products, today
announced that it will release financial results for the second
quarter of fiscal year 2019 ended December 31, 2018, before the
market open on Tuesday, February 5, 2019. The Company’s management
will host a webcast to discuss the results at 8:15 a.m. ET on the
same day.
Catalent invites all interested parties to listen to the
webcast, which will be accessible through Catalent’s website at
http://investor.catalent.com.
A supplemental slide presentation will also be available in the
“Investors” section of Catalent’s website prior to the start of the
webcast.
The webcast replay, along with the supplemental slides, will be
available for 90 days in the “Investors” section at
www.catalent.com.
About Catalent, Inc.
Catalent is the leading global provider of advanced delivery
technologies and development solutions for drugs, biologics and
consumer health products. With over 80 years serving the industry,
Catalent has proven expertise in bringing more customer products to
market faster, enhancing product performance and ensuring reliable
clinical and commercial product supply. Catalent employs over
11,000 people, including over 1,800 scientists, at more than 30
facilities across 5 continents and in fiscal 2018 generated
approximately $2.5 billion in annual revenue. Catalent is
headquartered in Somerset, N.J. For more information visit
www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190114005464/en/
Investor Contact:Thomas Castellano, Catalent, Inc.(732)
537-6325investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
From Apr 2023 to Apr 2024